Dávila AZME, Vega MME, Arenas GR

Language: Spanish
References: 10
Page: 306-309
PDF size: 267.87 Kb.

ABSTRACT

The twenty-nail dystrophy or trachyonychia can be idiopathic or secondary to systemic diseases. Clinically it presents changes in the nail plate that can be divided in two variants: opaque trachyonychia or bright trachyonychia. Histologically, spongiotic changes are observed in the nail plaque. Diagnosis includes a good clinical, dermatological history, nail or systemic diseases that affect other members of the family, as well as hair, nails and mucous membrane examination. Onychomycosis should be ruled out, and sometimes a biopsy can be performed. Treatment can be based on observation only, of nail lacquer, local or systemic steroid and cyclosporine should be used in severe cases.

REFERENCES

1. Tosti A, Bellavista S, Iorizzo M y Vincenzi C, Occupational trachyonychia due to psoriasis: report of a case successfully treated with oral acitretin, Contact Derm 2006; 54:123-4.

2. Haber J, Chairatchaneeboon M y Rubin A, Trachyonychia: review and update on clinical aspects, histology, and therapy, Skin Appendage Disord 2016; 2:109-15.

3. Chelidze K y Lipner S, Nail changes in alopecia areata: an update review, Int J Dermatol 2018; 57:776-83.

4. Tosti A, Piraccini B e Iorizzo M, Trachyonychia and related disorders: evaluation and treatment plans, Dermatol Ther 2002; 15:121-5.

5. Blanco FP y Scher RK, Trachyonychia: case report and review of the literature, jdd 2006; 5:469-72.

6. Tosti A, Brdazzi F, Piraccini B y Fanto P, Idipathic trachyonychia (twenty- nail dystrophy): a pathological study of 23 patients, Br J Dermatol 1994; 131:866-72. Traquioniquia OBSERVACIÓN Caso grave/recidivante Estudio histopatológico Caso leve/moderado Uso corto de medicamento tópico Tratamiento sistémico acorde Traquioniquia asociada a enfermedad sistémica Traquioniquia idiopática Esteroide inyectado Calcipotriol/dipropionato de betametasona ungüento diario durante 6 meses7 Acetónido de triamcinolona intralesional en una sola dosis de 2.5-10 mg/ml8 Ciclosporina 2.5-3 mg/kg/día, si hay mejoría, disminuir a 1.5 mg/kg/día por 8-24 meses9 Ciclosporina 2.5-3 mg/kg/día por 3 meses con destete de 0.5 mg/kg/día cada 2 semanas10 Figura 2. Algoritmo terapéutico.

7. Park JM, Cho HH, Kim WJ, Mun JH, Song M, Kim HS et al., Efficacy and safety of calcipotriol/betamethasone dipropionate ointment for the treatment of trachyonychia: an openlabel study, Ann Dermatol 2015; 27:371-5.

8. Khoo BP y Giam YC, A pilot study on the role of intralesional triamcinolone acetonide in the treatment of pitted nails in children, Singapore Med J 2000; 41:66-68.

9. Lee YB, Cheon MS, Eun YS, Cho BK, Park YG y Park HJ, Cyclosporin administration improves clinical manifestations and quality of life in patients with 20-nail dystrophy: case series and survey study, J Dermatol 2012; 39:1064-5.

10. Pierard GE y Pierard-Franchimont C, Dynamics of psoriatic trachyonychia during lowdose cyclosporin A treatment: a pilot study on onychochronobiology using optical profilometry, Dermatology 1996; 192:116-9.